Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY – Get Free Report) gapped up before the market opened on Thursday . The stock had previously closed at $79.32, but opened at $86.62. Sandoz Group shares last traded at $86.69, with a volume of 782 shares trading hands.
Analyst Ratings Changes
Separately, Barclays raised Sandoz Group from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 5th. Three equities research analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Sandoz Group has a consensus rating of “Strong Buy”.
Check Out Our Latest Stock Report on SDZNY
Sandoz Group Price Performance
About Sandoz Group
Sandoz Group (OTCMKTS:SDZNY) is a multinational pharmaceutical company focused on the development, manufacturing and commercialization of generic medicines and biosimilars. The company supplies off-patent small-molecule drugs as well as biologic alternatives intended to offer lower-cost therapeutic options across a range of clinical areas. Sandoz emphasizes access and affordability, positioning its portfolio to serve hospitals, pharmacies and health systems looking to expand patient access to essential therapies.
The company’s product offerings span conventional generics, complex and specialty generics, and a growing pipeline of biosimilar medicines.
Further Reading
- Five stocks we like better than Sandoz Group
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Sandoz Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sandoz Group and related companies with MarketBeat.com's FREE daily email newsletter.
